Core Viewpoint - The article highlights that Yushu Technology Co., Ltd. has completed its IPO counseling work and is expected to submit its IPO application soon, marking a record for the listing process of hard technology companies in less than four months since the counseling began on July 18, 2025 [2]. Group 1: Company Overview - Yushu Technology Co., Ltd. is preparing to apply for its initial public offering (IPO) in China, with CITIC Securities acting as the counseling institution [3]. - The counseling agreement was signed on July 7, 2025, and the work was conducted in accordance with relevant regulations [3]. Group 2: Counseling Work Conducted - The counseling work included comprehensive training for personnel on regulatory knowledge, promoting understanding of responsibilities and obligations as a public company [3]. - The company was urged to establish a governance structure that meets modern enterprise standards and enhance legal awareness and integrity among its personnel [4]. - The counseling team verified the legality and effectiveness of the company's establishment, equity transfers, capital increases, and asset evaluations [4][5]. - The team also ensured that the company operated independently and established sound internal decision-making and control systems [5]. Group 3: Issues Identified and Improvements - Initially, the company's fundraising project planning was not finalized, but the counseling team assisted in determining a feasible fundraising direction based on industry trends and competitive advantages [6]. - The company lacked independent directors and specialized board committees at the start of the counseling period, but by the end, it had appointed three independent directors and established necessary committees [7]. Group 4: Counseling Effectiveness - The counseling plan was effectively executed, with both CITIC Securities and the company fulfilling their responsibilities diligently [8]. - The company established a governance structure compliant with public company requirements, ensuring independent operation of its board and management [9]. - The company developed comprehensive management systems covering various operational aspects, ensuring compliance and risk control [9]. Group 5: Understanding of Securities Market - Under the guidance of the counseling institution, the company and its personnel have gained a solid understanding of the legal regulations and responsibilities related to public offerings and compliance [10]. - The personnel are now well-informed about the characteristics and requirements of different segments of the multi-tiered capital market [11]. Group 6: Conclusion - CITIC Securities concludes that Yushu Technology Co., Ltd. possesses the necessary governance structure, accounting foundation, and internal control systems to qualify as a public company [12].

Core Viewpoint - Sichuan Jinjiang Electronic Medical Equipment Technology Co., Ltd. has submitted an IPO guidance filing to the securities regulatory authority, marking its second attempt at an IPO within three years [1] Group 1: IPO Attempts - Jinjiang Electronic previously attempted to launch an IPO on the Sci-Tech Innovation Board in June 2023 but withdrew its application after just one round of inquiries, leading to the termination of the IPO review [2] - The underwriting institution for both of Jinjiang Electronic's IPO attempts has been CITIC Securities [2] Group 2: Disclosure Inconsistencies - CITIC Securities noted in the IPO guidance materials that Jinjiang Electronic has not had any IPO applications terminated, which contradicts the company's recent history of withdrawing its application [5] - In contrast, another company, Aike Medical, which also attempted an IPO twice, had detailed disclosures regarding its previous application withdrawal and termination, raising questions about the consistency of disclosures by CITIC Securities [4][5] Group 3: Product Focus and Market Competition - Jinjiang Electronic focuses on electrophysiological three-dimensional mapping systems, catheters, radiofrequency ablation, and various consumables, with its most innovative product being the Pulsed Field Ablation (PFA) system, which is expected to receive approval from the National Medical Products Administration in 2024 [5] - The PFA system represents a significant advancement over existing ablation techniques, offering advantages such as shorter treatment times and reduced risk of complications [6] - However, the PFA market is becoming increasingly competitive, with several domestic medical device companies, including Huitai Medical and Aike Mai, also receiving approvals for their PFA products by the end of 2024 [6][7]

Core Viewpoint - Shanghai Tiro Medical Co., Ltd. has completed its IPO counseling registration with the Shanghai Securities Regulatory Bureau, indicating its intention to go public [1][2]. Company Overview - Tiro Medical was established on July 3, 2017, with a registered capital of 44.266 million yuan [1]. - The company is a major domestic player in the research, design, and production of cosmetic contact lenses in China [1]. Shareholding Structure - The controlling shareholder, Jin Yilin, directly holds 33.21% of the shares and indirectly holds an additional 0.07% through Zhoushan Meimu Sutong Equity Investment Partnership (Limited Partnership), totaling 33.27% [2].

Group 1 - The core point of the article is that Suzhou Fatedi Technology Co., Ltd. has registered for guidance with the Jiangsu Securities Regulatory Bureau to prepare for its initial public offering (IPO) and listing on the A-share market [1] - The guidance for the IPO is being provided by CITIC Securities [1]

Core Points - Beijing Securities Regulatory Bureau emphasizes the importance of enhancing the quality of listed companies by implementing strict requirements for IPO counseling institutions [1][6] - The meeting outlined four specific requirements for counseling institutions to ensure high-quality listings and prevent substandard companies from entering the market [2][6] Group 1: Requirements for Counseling Institutions - Diligence and Responsibility: Counseling institutions must conduct thorough due diligence and help companies establish robust governance, financial management, and internal control systems [2][6] - Accountability: Institutions are required to take responsibility for the quality of projects they submit, ensuring accurate and complete financial disclosures to prevent fraud [3][6] - Focus on New Productive Forces: Institutions should align their services with national strategic directions, particularly supporting technology innovation companies and capitalizing on policy benefits [4][6] - Integrity and Self-Discipline: Emphasis on maintaining ethical standards and preventing improper competition and corruption within the counseling institutions [5][6] Group 2: Regulatory Context - The meeting highlighted the achievements of the Beijing Securities Regulatory Bureau in enhancing IPO counseling and the positive outcomes, including the addition of 20 new counseling companies and 3 new listed companies this year [7][8] - The year 2025 is identified as a critical year for implementing comprehensive reforms and supporting high-quality development in the capital market [8]

Core Insights - Shandong Huiyan Tong Medical Technology Group Co., Ltd. (referred to as Huiyan Tong) has reported on the progress of its initial public offering (IPO) guidance work, with Zhongtai Securities acting as the advisory institution [2] - The IPO guidance was officially filed on July 28, 2020, and the current concentrated guidance period is from July 1, 2025, to September 30, 2025, lasting for three months [2] - The guidance team has identified a betting agreement between the actual controller and Suzhou Dingfeng Jiuding Investment Center (Limited Partnership) and Suzhou Yinli Jiuding Investment Center (Limited Partnership), and is actively facilitating communication regarding this issue [2] Company Overview - Huiyan Tong was established on May 31, 2004, with a registered capital of 81.5 million yuan, and its business scope includes economic trade consulting, sales of Class II and III medical devices, and computer system services [3] - The company is primarily owned by its chairman and general manager, Gao Fujun, who holds 56.06% of the shares, with Jiuding Investment as a minority shareholder [3] - Gao Fujun is a prominent figure in the medical field, serving as the director of the Lunan Eye Hospital and holding various leadership roles in medical associations, recognized for his contributions to charity and healthcare [3]

Group 1 - Jia De Li Electronic Materials Co., Ltd. (Jia De Li) has completed its initial public offering (IPO) guidance work, with Guangfa Securities as the guiding institution [2] - The guidance agreement was signed on December 2, 2024, and the guidance work was conducted from December 2, 2024, to October 10, 2025, comprising three phases [2] - During the second phase of guidance, external investors were introduced, increasing the company's registered capital from 396 million to 413 million yuan, establishing a more reasonable equity structure [2] Group 2 - Jia De Li, established in 2002, is a high-tech enterprise specializing in the research, development, and production of high-quality polypropylene films for capacitors, and is one of the largest manufacturers of capacitor films in China [3] - The company has been recognized as a "National Specialized and Innovative Small Giant" [3] - Key management includes Chairman Huang Huanming, General Manager Huang Zezhong, Vice General Manager Huang Yanhuang, and Financial Officer Huang Kunfeng [3]

Core Points - Dalian Otto Co., Ltd. has disclosed its progress report on the guidance for its initial public offering (IPO) [1] - The company started its IPO guidance filing with the Dalian Securities Regulatory Bureau in October 2021, with the current guidance period set from July 1, 2025, to September 30, 2025 [1] - Dalian Otto specializes in the planning, design, manufacturing, and system integration of automotive body equipment and is recognized as a high-tech enterprise [1] Funding and Project Development - The company is still in the process of researching and discussing the intended use of funds to be raised from the IPO, and the construction plan for the fundraising projects has not yet been finalized [2] - Dalian Otto was established in October 1990 and has undergone a transformation from a collective enterprise, which raises questions regarding the approval of its restructuring actions and the legality of the processes involved [2]

Group 1 - The core viewpoint of the article is the progress report on the IPO guidance work of Chongqing Senqianye New Materials Technology Co., Ltd. (referred to as "Senqianye") published by Industrial Securities [2] - Senqianye initiated its IPO guidance filing with the Chongqing Securities Regulatory Bureau in February 2023, with the current guidance period running until April 10, 2025 [2] - Senqianye, established in 2009, specializes in the research, production, and sales of lithium-ion battery graphite anode materials, new graphite materials, and other carbon-graphite products, recognized as a "Chongqing Technology Enterprise" [2] Group 2 - The major shareholder of Senqianye is Chongqing Huihao Market Management Co., Ltd., holding 86.33% of the shares [2] - The actual controller of Senqianye is Yang Xiugang, who holds a total shareholding ratio of 54.23% and a voting power ratio of 89.81% [2] - In early 2023, Senqianye held a year-end sharing meeting for 2024 and signed a target responsibility letter for 2025, during which former chairman Yang Xiugang officially announced his resignation, and Yang Binhui was appointed as the new chairman [2]

Group 1 - The core viewpoint of the article is that Chongqing Senqianye New Materials Technology Co., Ltd. is progressing with its IPO guidance work, having initiated the process in February 2023 and reporting on its status as of September 5, 2023 [2] - Senqianye was established in 2009 and specializes in the research, production, and sales of lithium-ion battery graphite anode materials, new graphite materials, and other carbon-graphite products [2] - The major shareholder of Senqianye is Chongqing Huhao Market Management Co., Ltd., which holds an 86.33% stake in the company [2] Group 2 - The guidance report indicates that Senqianye's business processes and internal control systems are generally compliant, but there is a need for further implementation of relevant internal control measures [3] - The guidance working group will collaborate with other intermediaries to continuously urge Senqianye to strengthen its internal controls and standardize operations [3]